ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0QN1 Santhera Pharmaceuticals Holding Ag

190.20
0.00 (0.00%)
May 15 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 4.32M19.03M22.94M31.66M75.38M15.01M-1.6M7.47M
Operating Income 3.17M-33.13M-50.45M-51.42M-10.44M-53.08M-56.89M-51.98M
Pre Tax Income 2.93M-33.19M-51.28M-53.86M-18.39M-67.46M-54.72M-70.62M
Net Income 5.95M-35.42M-51.53M-54.19M-18.97M-67.66M-55.53M-71.08M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.95-5.643-8.207-5.081-1.699-3.732-1.12-0.944
EBIT 3.17M-33.13M-50.45M-51.42M-10.44M-53.08M-56.89M-51.98M
EBITDA 4.3M-29.86M-47.07M-47.68M-5.67M-45.93M-53.16M-48.33M